resveratrol has been researched along with guaifenesin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, K; Kim, S; Kwon, OK; Lee, HK; Lee, M; Oh, SR | 1 |
| Chen, G; Chen, QG; Lai, YM; Li, Z; Luo, XM; Ni, ZH; Tang, JH; Wang, XB; Yang, W | 1 |
| Chen, J; Han, X; Liu, R; Lu, Y; Peng, D; Song, G; Xia, Y; Yang, X; Zhang, W; Zhu, J | 1 |
| Almeida, A; Boni, FI; Cury, BSF; Ferreira, NN; Gremião, MPD; Prezotti, FG; Sarmento, B; Silva, DS; Vasconcelos, T | 1 |
| Duan, L; Xiao, B; Xie, D; Zhou, X; Zhu, Z | 1 |
5 other study(ies) available for resveratrol and guaifenesin
| Article | Year |
|---|---|
Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchoalveolar Lavage Fluid; Dexamethasone; Disease Models, Animal; Eosinophilia; Female; Goblet Cells; Immunoglobulin E; Immunoglobulin G; Interleukin-4; Interleukin-5; Lung; Mice; Mice, Inbred BALB C; Mucus; Ovalbumin; Resveratrol; Stilbenes | 2009 |
Resveratrol inhibits mucus overproduction and MUC5AC expression in a murine model of asthma.
Topics: Animals; Asthma; Cell Line; Disease Models, Animal; Epithelial Cells; Female; Gene Expression Regulation; Humans; Lung; Mice, Inbred BALB C; Mucin 5AC; Mucus; Pneumonia; Resveratrol; Stilbenes | 2016 |
Therapeutic Effects of Resveratrol in a Mouse Model of LPS and Cigarette Smoke-Induced COPD.
Topics: Animals; Beclin-1; Bronchoalveolar Lavage Fluid; Cytokines; Lipopolysaccharides; Lung; Mice; Mucus; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Resveratrol; Smoke; Stilbenes | 2016 |
Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol.
Topics: Administration, Oral; Animals; Caco-2 Cells; Cell Line, Tumor; Colon; Drug Carriers; Drug Liberation; HT29 Cells; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Male; Mucus; Nanoparticles; Particle Size; Pectins; Permeability; Polysaccharides, Bacterial; Rats; Rats, Wistar; Resveratrol | 2020 |
Mucus-Penetrating Silk Fibroin-Based Nanotherapeutics for Efficient Treatment of Ulcerative Colitis.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Dextran Sulfate; Drug Carriers; Fibroins; Humans; Lipopolysaccharides; Mucus; Nanoparticles; Poloxamer; Reactive Oxygen Species; Resveratrol; Tumor Necrosis Factor-alpha | 2022 |